Table 1d. The relationship between patient characteristics, mGPS and survival in patients sampled within 2 years before cancer diagnosis in the Glasgow Inflammation Outcome Study.
|
Overall survival
|
Cancer-specific survival
|
|||||
|---|---|---|---|---|---|---|
| n=9608 | HR | 95 % CI | P-value | HR | 95 % CI | P-value |
| Age | ||||||
| ⩽65 years | 1 | <0.001 | 1 | <0.001 | ||
| 65–74 years | 1.35 | 1.26–1.43 | <0.001 | 1.20 | 1.13–1.29 | <0.001 |
| ⩾75 years | 1.93 | 1.80–2.06 | <0.001 | 1.59 | 1.48–1.70 | <0.001 |
| Sex | ||||||
| Male | 1 | 0.037 | 1 | 0.132 | ||
| Female | 0.94 | 0.037 | 0.95 | 0.132 | ||
| SIMD | ||||||
| 1 (least deprived) | 1 | <0.001 | 1 | 0.003 | ||
| 2 | 1.02 | 0.684 | 1.02 | 0.773 | ||
| 3 | 1.09 | 0.090 | 1.09 | 0.136 | ||
| 4 | 1.16 | 1.06–1.27 | 0.002 | 1.12 | 0.025 | |
| 5 (most deprived) | 1.22 | 1.12–1.33 | <0.001 | 1.17 | 1.06–1.28 | 0.001 |
| mGPS | ||||||
| 0 | 1 | <0.001 | 1 | <0.001 | ||
| 1 | 1.79 | 1.68–1.91 | <0.001 | 1.92 | 1.79–2.06 | <0.001 |
| 2 | 2.87 | 2.68–3.08 | <0.001 | 3.01 | 2.79–3.24 | <0.001 |
Abbreviations: HR=hazard ratio; CI=confidence interval; SIMD=Scottish Index of Multiple Deprivation; mGPS=modified Glasgow Prognostic Score.
Multivariate analysis stratified by tumour site.